We describe a powerful new information resource for pharmacovigilance,
pharmaco-economic studies, clinical epidemiology and health service r
esearch, which involves automated linkage of demographic, diagnostic a
nd prescription information on some 3.4 million patients enrolled in o
ver 500 separate general practices. Information is subject to regular
validation checks. Access to this resource is available for bona fide
research workers, subject to appropriate safeguards for patient anonym
ity and for scientific and ethical standards of the proposed studies.
This database has depended upon the participating general practitioner
s and has already resulted in a substantial output of studies in peer-
reviewed literature. It has great potential for further work of major
relevance to public health, and its increasing use is to be actively e
ncouraged.